Heron Therapeutics reports $5.5 million loss in Q2
HRTX Heron Therapeutics Inc
$0.33 -10.35%
View chart & analysis → - 1Heron Therapeutics (HRTX) announced on Monday that it posted a $5.5 million loss in the second quarter
- 2Loss per share came in at 3 cents, while revenue for the same period totaled $37.7 million
- 3The North Carolina-based pharmaceutical company disclosed its Q2 earnings and revenue results
Source Associated Press +1 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.